Charles Cheng

Charles Cheng is an experienced professional in the biomedical field, currently serving as a Senior Medical Writer at Envision Pharma Group since September 2016, specializing in the production of high-quality manuscripts, congress posters, oral presentations, and abstracts. Prior experience includes working as an Investigator at Bristol-Myers Squibb from May 2008 to February 2016, where collaboration with Intellicyt Corp. led to the adaptation of a high-throughput flow cytometer for a novel assay. As a Corporate and Business Development Analyst at Neurogen Corporation from March 1997 to April 2008, responsibilities included authoring proposals for academic collaborations, particularly with Yale University, and serving as a Scientist focused on assay design and development, notably creating a proprietary biosensor technology for drug screening. Charles Cheng holds a Master of Science in Molecular Biophysics and Biochemistry from Yale University and a Bachelor of Science in Biochemistry from Trinity College-Hartford.